Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Shares Issued (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Shares Issued for 12 consecutive years, with $631000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued changed N/A year-over-year to $631000.0, compared with a TTM value of $186657.0 through Sep 2025, up 231.45%, and an annual FY2024 reading of $68000.0, down 56.13% over the prior year.
  • Shares Issued was $631000.0 for Q3 2025 at Lisata Therapeutics, up from -$520343.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $631000.0 in Q3 2025 and bottomed at -$520343.0 in Q2 2025.
  • Average Shares Issued over 3 years is $50276.2, with a median of $38000.0 recorded in 2024.
  • Peak annual rise in Shares Issued hit 147.89% in 2024, while the deepest fall reached 147.89% in 2024.
  • Year by year, Shares Issued stood at -$142000.0 in 2023, then surged by 147.89% to $68000.0 in 2024, then soared by 827.94% to $631000.0 in 2025.
  • Business Quant data shows Shares Issued for LSTA at $631000.0 in Q3 2025, -$520343.0 in Q2 2025, and $8000.0 in Q1 2025.